サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1650929

人工授精の世界市場

Artificial Insemination

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
人工授精の世界市場
出版日: 2025年02月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

人工授精の世界市場は2030年までに46億米ドルに達する

2024年に30億米ドルと推定される人工授精の世界市場は、2024年から2030年にかけてCAGR 7.2％で成長し、2030年には46億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである子宮内人工授精は、CAGR 7.7％を記録し、分析期間終了までに28億米ドルに達すると予測されます。子宮頸管内人工授精セグメントの成長率は、分析期間中CAGR 7.0％と推定されます。

米国市場は8億4,000万米ドルと推定、中国はCAGR6.7％で成長予測

米国の人工授精市場は、2024年に8億4,000万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに7億340万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.0％と5.8％と予測されています。欧州では、ドイツがCAGR 5.8%で成長すると予測されています。

世界の人工授精市場- 主要動向と促進要因のまとめ

人工授精が不妊治療において重要な選択肢になりつつある理由とは？

人工授精（AI）は、不妊の問題に直面しているカップルや個人にとって極めて重要な選択肢として浮上しており、他の生殖補助医療技術よりも侵襲性が低く、多くの場合、より手頃な選択肢を提供しています。この方法は、女性の子宮、子宮頸部、卵管に精子を直接導入することで、受精の可能性を高めるものです。体外受精（IVF）のような複雑な治療に比べ、AIは簡単で利用しやすいため、自然妊娠が困難な人に人気の治療法となっています。AIは、軽度の男性不妊、原因不明の不妊、精子の移動性を妨げる子宮頸管粘液の問題がある場合に特に有効です。さらに、AIは同性カップルや独身女性、精子提供を希望する人にとっても不可欠な方法です。出産の遅れやライフスタイルの変化などの要因で不妊率が世界的に上昇する中、人工授精は、個人やカップルが家族形成の目標を達成するために重要な役割を果たし続けています。

技術の進歩は人工授精の成功率をどのように高めていますか？

技術の進歩は、人工授精の効果と成功率を大幅に向上させ、不妊治療を希望される方にとって、より信頼できる選択肢となっています。高度な精子選別法の使用や精子保存技術の開発など、精子の選別と調製技術の革新により、AI法で使用される精子の品質と生存率が向上しました。さらに、遺伝子スクリーニングと選別プロセスの統合により、最も健康な精子のみが使用されるようになり、妊娠成功の可能性がさらに高まっています。超音波ガイド下での人工授精技術の登場により、精子の配置の精度も向上し、受精の可能性が最大限に高まった。さらに、AIと機械学習による患者データの分析と治療結果の予測により、不妊治療の専門医はより効果的に治療を調整できるようになり、AIによる全体的な成功率が向上しています。このような技術の進歩は、不妊の課題を抱える多くの個人やカップルの第一選択治療としてのAIの採用を後押ししています。

世界中でどのような動向が人工授精の採用を形成しているか？

生殖医療におけるより広範な社会の変化と進歩を反映し、いくつかの重要な動向が人工授精の世界の導入に影響を与えています。キャリアの優先順位やライフスタイルの選択によって、親になる時期を遅らせる傾向が強まっているため、AIを含む不妊治療のニーズが高まっています。さらに、単身赴任や同性カップルが家庭を築こうとすることが社会的に受け入れられるようになり、ドナー精子サービスやAI手術の需要が拡大しています。医療ツーリズムも重要な動向であり、多くの個人やカップルが、AIを含む不妊治療がより利用しやすい、あるいは手頃な価格で受けられる国へ旅行しています。新興市場における不妊治療クリニックの拡大も、AIの世界的成長に寄与しています。これらの地域では、生殖サービスに対する需要の高まりに対応するため、高度なヘルスケア・インフラに投資しているからです。さらに、不妊治療における遠隔医療の統合は、AIをより身近なものにし、患者が遠隔で診察を受けたり、治療経過をモニターしたりすることを可能にし、それによってAIサービスの到達範囲を広げています。

人工授精市場の成長を促進する要因とは？

人工授精市場の成長は、不妊治療の状況を変えつつあるいくつかの要因によって牽引されています。主な要因としては、ライフスタイルの変化、環境要因、出産の遅れといった動向の影響を受けた世界の不妊率の増加が挙げられます。技術の進歩、特に精子保存、遺伝子スクリーニング、AIによる患者管理は、AI手術の成功率を高め、より幅広い患者にとって魅力的なものとなっています。新興市場における不妊治療サービスの利用可能性の拡大も、AIに対する認識とアクセシビリティの高まりと相まって、市場の成長を後押ししています。加えて、同性カップル、シングルペアレント、ドナー精子を求める個人からの需要の高まりは、AIの対応可能市場を大幅に拡大しています。不妊治療を支援する政府の規制や保険適用がさらに普及を後押しし、AIは多くの人にとってより現実的で利用しやすい選択肢となっています。こうした動向が進化を続ける中、人工授精市場は、技術革新、社会の変化、利用しやすい不妊治療ソリューションへの需要の高まりによって、持続的な成長を遂げる態勢を整えています。

セグメント

タイプ（子宮内、子宮頸管内、膣内、卵管内）、供給源タイプ（AIH-夫、AID-ドナー）、最終用途（不妊治療センター、病院＆クリニック、その他の最終用途）

調査対象企業の例（合計 41注目）

  • Genea Limited
  • Hi-Tech Solutions
  • Irvine Scientific
  • KITAZATO CORPORATION
  • Pride Angel Ltd.
  • Rinovum Women's Health, LLC.
  • Rocket Medical PLC
  • Vitrolife AB

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10380

Global Artificial Insemination Market to Reach US$4.6 Billion by 2030

The global market for Artificial Insemination estimated at US$3.0 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Intrauterine Insemination, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Intracervical Insemination segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$840.0 Million While China is Forecast to Grow at 6.7% CAGR

The Artificial Insemination market in the U.S. is estimated at US$840.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$703.4 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Artificial Insemination Market - Key Trends and Drivers Summarized

Why Is Artificial Insemination Becoming a Crucial Option in Fertility Treatments?

Artificial insemination (AI) has emerged as a pivotal option for couples and individuals facing infertility issues, offering a less invasive and often more affordable alternative to other assisted reproductive technologies. This procedure involves directly introducing sperm into a woman's uterus, cervix, or fallopian tubes, thereby increasing the likelihood of fertilization. The simplicity and accessibility of AI, compared to more complex treatments like in vitro fertilization (IVF), have made it a popular choice for those experiencing difficulties conceiving naturally. AI is particularly beneficial in cases of mild male infertility, unexplained infertility, or cervical mucus issues that impede sperm mobility. Additionally, AI is an essential method for same-sex couples, single women, and those who opt for donor sperm. As infertility rates rise globally due to factors such as delayed childbearing and lifestyle changes, artificial insemination continues to play a vital role in helping individuals and couples achieve their family-building goals.

How Are Technological Advances Enhancing the Success Rates of Artificial Insemination?

Technological advancements have significantly enhanced the effectiveness and success rates of artificial insemination, making it a more reliable option for those seeking fertility treatment. Innovations in sperm selection and preparation techniques, such as the use of advanced sperm sorting methods and the development of sperm preservation technologies, have improved the quality and viability of sperm used in AI procedures. Additionally, the integration of genetic screening and selection processes ensures that only the healthiest sperm are used, further increasing the chances of successful conception. The advent of ultrasound-guided insemination techniques has also improved the precision of sperm placement, maximizing the likelihood of fertilization. Moreover, the use of AI and machine learning in analyzing patient data and predicting outcomes has allowed fertility specialists to tailor treatments more effectively, improving the overall success rates of AI. These technological advancements are driving the adoption of AI as a first-line treatment for many individuals and couples experiencing fertility challenges.

What Trends Are Shaping the Adoption of Artificial Insemination Worldwide?

Several key trends are influencing the adoption of artificial insemination globally, reflecting broader societal changes and advancements in reproductive healthcare. The increasing trend towards delayed parenthood, driven by career priorities and lifestyle choices, has led to a growing need for fertility treatments, including AI. Additionally, the rising social acceptance of single parenthood and same-sex couples seeking to start families has expanded the demand for donor sperm services and AI procedures. Medical tourism is another significant trend, with many individuals and couples traveling to countries where fertility treatments, including AI, are more accessible or affordable. The expansion of fertility clinics in emerging markets is also contributing to the global growth of AI, as these regions invest in advanced healthcare infrastructure to meet the rising demand for reproductive services. Furthermore, the integration of telemedicine in fertility care has made AI more accessible, allowing patients to receive consultations and monitor their treatment progress remotely, thereby broadening the reach of AI services.

What Factors Are Driving the Growth of the Artificial Insemination Market?

The growth in the artificial insemination market is driven by several factors that are reshaping the landscape of fertility treatment. A major driver is the increasing infertility rates worldwide, influenced by factors such as lifestyle changes, environmental factors, and the trend of delayed childbearing. Technological advancements, particularly in sperm preservation, genetic screening, and AI-driven patient management, are enhancing the success rates of AI procedures, making them more appealing to a broader range of patients. The expanding availability of fertility services in emerging markets, coupled with growing awareness and accessibility of AI, is also propelling market growth. Additionally, the rising demand from same-sex couples, single parents, and individuals seeking donor sperm has significantly expanded the addressable market for AI. Government regulations and insurance coverage that support fertility treatments further drive adoption, making AI a more viable and accessible option for many. As these trends continue to evolve, the artificial insemination market is poised for sustained growth, driven by innovation, societal shifts, and increasing demand for accessible fertility solutions.

SCOPE OF STUDY:

The report analyzes the Artificial Insemination market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Intrauterine, Intracervical, Intravaginal, Intratubal); Source Type (AIH-Husband, AID-Donor); End-Use (Fertility Centers, Hospitals & Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Genea Limited
  • Hi-Tech Solutions
  • Irvine Scientific
  • KITAZATO CORPORATION
  • Pride Angel Ltd.
  • Rinovum Women's Health, LLC.
  • Rocket Medical PLC
  • Vitrolife AB

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Artificial Insemination - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Infertility Rates Propel Growth in Artificial Insemination Services
    • Advancements in Sperm Preservation and Handling Strengthen Business Case for Artificial Insemination
    • Increasing Acceptance of Assisted Reproductive Technologies Expands Addressable Market
    • Shift Towards Delayed Parenthood Spurs Demand for Fertility Treatments
    • Innovations in Genetic Screening and Selection Enhance Success Rates
    • Expansion of Fertility Clinics in Emerging Markets Generates New Opportunities
    • Rising Demand for Sperm Banks and Donor Services Expands Market
    • Increasing Medical Tourism for Fertility Treatments Propels Market Expansion
    • Rising Single Parenthood and Same-Sex Couples Seeking Reproductive Assistance Propel Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Artificial Insemination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Artificial Insemination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Artificial Insemination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Artificial Insemination Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Intrauterine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Intrauterine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Intrauterine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Intracervical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Intracervical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Intracervical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Intravaginal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Intravaginal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Intravaginal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Intratubal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Intratubal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Intratubal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for AIH-Husband by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for AIH-Husband by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for AIH-Husband by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for AID-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for AID-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for AID-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Fertility Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Fertility Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Fertility Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Artificial Insemination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Artificial Insemination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Artificial Insemination by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION